Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer

Abstract Patients with early-stage, hormone receptor–positive breast cancer with favorable clinicopathologic features are often not recommended for extended endocrine therapy. However, even patients with T1N0 disease remain at significant risk of distant recurrence up to 15 years following 5 years o...

Full description

Saved in:
Bibliographic Details
Main Authors: Brock Schroeder, Yi Zhang, Olle Stål, Tommy Fornander, Adam Brufsky, Dennis C. Sgroi, Catherine A. Schnabel
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Online Access:https://doaj.org/article/92e90599335f479b9f2cb277f9642bd4
Tags: Add Tag
No Tags, Be the first to tag this record!